v3.26.3
Composition of Other Balance Sheet Items (Tables)
 9 Months Ended
Sep. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Inventory, Current
September 30,
2026		December 31,
2025
(unaudited)
Raw materials$29,120 $31,833 
Work in process24,843 29,436 
Finished goods33,149 21,116 
Total$87,112 $82,385 
Schedule of Inventory, Current and Noncurrent
Inventories, net as reported on the condensed consolidated balance sheets are as follows (dollars in thousands):
Balance Sheet ClassificationSeptember 30, 2026December 31, 2025
(unaudited)
Current inventory
Inventories, net
$87,112 $82,385 
Noncurrent inventory
Other Assets
26,131 30,095 
Total $113,243 $112,480 
Schedule of Property and Equipment Property and Equipment, Net
September 30,
2026		December 31,
2025
(unaudited)
Lab equipment and furniture$14,538 $14,041 
Leasehold improvements13,052 13,052 
Software951 871 
Computer equipment1,052 831 
Subtotal29,593 28,795 
Less accumulated depreciation and amortization(19,572)(18,264)
Property and equipment, net$10,021 $10,531 
Schedule of Accounts Payable and Accrued Liabilities
Accounts Payable and Accrued Liabilities
September 30,
2026		December 31,
2025
(unaudited)
Accrued manufacturing expenses$29,874 $25,608 
Accrued compensation, benefits, & related accruals27,596 29,446 
Accrued sales & marketing14,220 16,665 
Operating lease liabilities, current portion(a)
7,620 10,612 
Accounts payable8,517 2,677 
Accrued R&D expenses6,592 7,299 
Accrued royalties(b)
622 2,403 
Other accrued expenses14,095 13,090 
Total$109,136 $107,800 
_______________________________
(a) Refer to Note 13, Leases.
(b) Refer to Note 17, Commitments and Contingencies.
Schedule of Accrued Sales Deductions
Accrued Product Returns and Rebates
September 30,
2026		December 31,
2025
(unaudited)
Accrued product rebates$131,537 $123,297 
Accrued product returns33,811 37,800 
Total$165,348 $161,097